These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 11830532)

  • 1. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
    Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
    Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
    Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
    J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy.
    Kanyama H; Tomita N; Yamano T; Aihara T; Miyoshi Y; Ohue M; Sekimoto M; Sakita I; Tamaki Y; Kaneda Y; Senter PD; Monden M
    Cancer Res; 2001 Jan; 61(1):14-8. PubMed ID: 11196152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
    Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
    C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.
    Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y
    Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
    Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
    Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of AdCMVCD/5-FC system and metabolism of 5-FC in the treatment of human tongue squamous cell carcinoma.
    Wang A; Huang H; Li S
    Chin Med J (Engl); 2003 Feb; 116(2):248-52. PubMed ID: 12775241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
    Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
    Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
    Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
    Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.